SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avadel AVDL -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (185)9/5/2007 6:12:25 PM
From: Arthur Radley  Respond to of 240
 
As someone mentioned OSS(Oscar Shafer) has staked their money, big time, on FLML. It was his efforts that ousted the original CEO and replaced him with Willard. A good move IMO!
At this point and with his hefty stake it would be a good move to take the company private and hope the technology has future value. Still have fond memories of the run to over $40.00 and me unloading....but don't think we will see anything in that order in the near future.

What ever happened to the herpes drug?



To: tuck who wrote (185)9/5/2007 9:12:59 PM
From: sammaster  Read Replies (1) | Respond to of 240
 
the purpose of that trial is more to show that combination of zestril and coreg cr is better than taking each alone.
everyone with CHF or post-MI uses both those drugs so would be nice to have to take only one pill a day, rather than 3 with one zestril and 2 generic coreg IR


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News